Cargando…
ANGPTL3 as therapeutic target
PURPOSE OF REVIEW: Elevated LDL-C and triglycerides are important risk factors for the development of atherosclerotic cardiovascular disease. Although effective therapies for lipid lowering exist, many people do not reach their treatment targets. In the last two decades, ANGPTL3 has emerged as a nov...
Autor principal: | Kersten, Sander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631155/ https://www.ncbi.nlm.nih.gov/pubmed/34581310 http://dx.doi.org/10.1097/MOL.0000000000000789 |
Ejemplares similares
-
PCSK9 inhibitors and cardiovascular disease: heralding a new therapeutic era
por: Chapman, M. John, et al.
Publicado: (2015) -
Targeting epigenetics as atherosclerosis treatment: an updated view
por: Neele, Annette E., et al.
Publicado: (2020) -
Splice correction therapies for familial hypercholesterolemic patients with low-density lipoprotein receptor mutations
por: McIntosh, Craig S., et al.
Publicado: (2021) -
New algorithms for treating homozygous familial hypercholesterolemia
por: Tromp, Tycho R., et al.
Publicado: (2022) -
Translating guidelines into practice via implementation science: an update in lipidology
por: Jones, Laney K., et al.
Publicado: (2022)